Clinical Trial Record

Return to Clinical Trials

Assessment of What Patients and Healthcare Providers Value


2020-06-11


2022-08-11


2022-08-11


397

Study Overview

Assessment of What Patients and Healthcare Providers Value

To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

PRIMARY OBJECTIVE: I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience). SECONDARY OBJECTIVES: I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery. II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence). III. To assess how patients' view differ to health providers. OUTLINE: Patients and healthcare providers complete a survey over 10-15 minutes.

  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Pancreatic Neuroendocrine Carcinoma
  • OTHER: Survey Administration
  • 2020-0211
  • NCI-2020-04577 (REGISTRY Identifier) (REGISTRY: CTRP (Clinical Trial Reporting Program))
  • 2020-0211 (OTHER Identifier) (OTHER: M D Anderson Cancer Center)
  • P30CA016672 (U.S. NIH Grant/Contract)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2020-07-14  

N/A  

2022-08-30  

2020-07-21  

N/A  

2022-08-31  

2020-07-23  

N/A  

2022-08  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Observational (survey administration)

Patients and healthcare providers complete a survey over 10-15 minutes.

OTHER: Survey Administration

  • Complete survey
Primary Outcome MeasuresMeasure DescriptionTime Frame
Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.Survey completion up to 1 year
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Most important attributes of value to healthcare providersProvider characteristics and survey items will be summarized using descriptive statistics, including means, SDs, proportions, range, and 95% CIs, etc.Survey completion up to 1 year
Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)Chi-square tests (or Fisher's exact test) will be used to compare the results between patients and providers.Survey completion up to 1 year

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
  • Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
  • Able to understand the description of the study and willing to participate

  • Exclusion Criteria:

  • Inability to read and answer questions in English

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Matthew H Katz, M.D. Anderson Cancer Center

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available